These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2245592)

  • 21. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different involvement of endothelium-derived relaxing factor and prostacyclin in vasodilator response to bradykinin in isolated dog blood vessels.
    Okamura T; Toda N
    Adv Exp Med Biol; 1989; 247A():429-34. PubMed ID: 2513706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.
    Nagao T; Vanhoutte PM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):1-6. PubMed ID: 8380248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of endothelium-formed nitric oxide on vascular responses.
    Marín J; Sánchez-Ferrer CF
    Gen Pharmacol; 1990; 21(5):575-87. PubMed ID: 2276579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the endothelium in the control of vascular motility: physiologic aspects and physiopathologic implications in cardiovascular diseases].
    Limone P; Boeri E; Molinatti GM
    Minerva Med; 1993 Oct; 84(10):499-505. PubMed ID: 8247303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion of nitric oxide and scavenging by blood in the vasculature.
    Butler AR; Megson IL; Wright PG
    Biochim Biophys Acta; 1998 Sep; 1425(1):168-76. PubMed ID: 9813307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myogenic autoregulation of flow may be inversely related to endothelium-derived relaxing factor activity.
    Griffith TM; Edwards DH
    Am J Physiol; 1990 Apr; 258(4 Pt 2):H1171-80. PubMed ID: 2331005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS
    Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.
    Dusting GJ; Read MA; Stewart AG
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of phospholamban in NO/EDRF-induced relaxation in rat aorta.
    Karczewski P; Kelm M; Hartmann M; Schrader J
    Life Sci; 1992; 51(15):1205-10. PubMed ID: 1528090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelium in ischemic heart disease: possible role for endothelium-derived relaxing factor.
    Henderson AH
    Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():241-8. PubMed ID: 2487797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-derived relaxing factors and converting enzyme inhibition.
    Vanhoutte PM; Boulanger CM; Mombouli JV
    Am J Cardiol; 1995 Nov; 76(15):3E-12E. PubMed ID: 7484885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endothelial mediators regulating vascular tonus].
    Gris JC; Schved JF; Aguilar-Martinez P; Arnaud A; Sanchez N
    Presse Med; 1991 Feb; 20(7):303-8. PubMed ID: 1826357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone.
    Azadzoi KM; Kim N; Brown ML; Goldstein I; Cohen RA; Saenz de Tejada I
    J Urol; 1992 Jan; 147(1):220-5. PubMed ID: 1370329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelium and control of vascular function. State of the Art lecture.
    Vanhoutte PM
    Hypertension; 1989 Jun; 13(6 Pt 2):658-67. PubMed ID: 2661425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
    Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction to EDRF research.
    Furchgott RF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
    Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
    Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.